When a member organisation takes the FSHD voice to the podium
At the World Orphan Drug Congress Europe 2026, FSHD Europe hosted a panel on how patient experience becomes evidence that health technology assessment bodies accept. The panel took place last week. Project Mercury was not on that stage. The questions raised there are the ones our Country Working Groups have